Evidence map›Paper›PMID 35705579›Full record

ArticleScientific reports2022

Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes.

Ahmed Mohyeldin, Laurence J Katznelson, Andrew R Hoffman, Karam Asmaro, Saman S Ahmadian, Mostafa M Eltobgy, Jayakar V Nayak, Zara M Patel, Peter H Hwang, Juan C Fernandez-Miranda

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Functional pituitary adenoma imaging.Reviews in endocrine & metabolic disorders · 2026
    Review
  6. Article
  7. Review
  8. Patency of the Cavernous Sinus After Medial Wall Resection: An Observational Study.Journal of neurological surgery. Part B, Skull base · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ahmed MohyeldinDepartment of Neurosurgery, Stanford University Medical Center, Stanford, California, USA.
Laurence J KatznelsonDepartment of Neurosurgery, Stanford University Medical Center, Stanford, California, USA.
Andrew R HoffmanDepartment of Neurosurgery, Stanford University Medical Center, Stanford, California, USA.
Karam AsmaroDepartment of Neurosurgery, Stanford University Medical Center, Stanford, California, USA.
Saman S AhmadianDepartment of Pathology, Stanford University Medical Center, Stanford, California, USA.
Mostafa M EltobgyDepartment of Microbiology, Ohio State University, Columbus, Ohio, USA.
Jayakar V NayakDepartment of Otolaryngology, Stanford University Medical Center, Stanford, California, USA.
Zara M PatelDepartment of Otolaryngology, Stanford University Medical Center, Stanford, California, USA.
Peter H HwangDepartment of Otolaryngology, Stanford University Medical Center, Stanford, California, USA.
Juan C Fernandez-MirandaDepartment of Neurosurgery, Stanford University Medical Center, Stanford, California, USA. drjfm@stanford.edu.
Stanford University · USStanford Medicine · USThe Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recurrence and biochemical remission rates vary widely among different histological subtypes of pituitary adenoma. In this prospective study, we evaluated 107 consecutive primary pituitary adenomas operated on by a single neurosurgeon including 28 corticotroph, 27 gonadotroph, 24 somatotroph, 17 lactotroph, 5 null-cell and 6 plurihormonal. In each case, we performed direct endoscopic intraoperative inspection of the medial wall of the cavernous sinus, which was surgically removed when invasion was visualized. This was performed irrespective of tumor functional status. Medial wall resection was performed in 47% of pituitary adenomas, and 39/50 walls confirmed pathologic evidence of invasion, rendering a positive predictive value of intraoperative evaluation of medial wall invasion of 78%. We show for the first-time dramatic disparities in the frequency of medial wall invasion among pathological subtypes. Somatotroph tumors invaded the medial wall much more often than other adenoma subtypes, 81% intraoperatively and 69% histologically, followed by plurihormonal tumors (40%) and gonadotroph cell tumors (33%), both with intraoperative positive predictive value of 100%. The least likely to invade were corticotroph adenomas, at a rate of 32% intraoperatively and 21% histologically, and null-cell adenomas at 0%. Removal of the cavernous sinus medial wall was not associated with permanent cranial nerve morbidity nor carotid artery injury, although 4 patients (all Knosp 3-4) experienced transient diplopia. Medial wall resection in acromegaly resulted in the highest potential for biochemical remission ever reported, with an average postoperative day 1 GH levels of 0.96 ug/L and surgical remission rates of 92% based on normalization of IGF-1 levels after surgery (mean = 15.56 months; range 3-30 months). Our findings suggest that tumor invasion of the medial wall of the cavernous sinus may explain the relatively low biochemical remission rates currently seen for acromegaly and illustrate the relevance of advanced intradural surgical approaches for successful and durable outcomes in endonasal pituitary surgery for functional adenomas.

Indexed as

AcromegalyAdenomaCavernous SinusPituitary NeoplasmsHumansNeoplastic ProcessesProspective StudiesRetrospective StudiesTreatment Outcome

Identifiers

PMID35705579
PMCPMC9200976
OpenAlexW4282915826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.